May 1, 2019
5,230,866
15,750
412
0.31%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
Pfizer was making $1.8 billion a year on average from Viagra when the erectile dysfunction drug first appeared on the market. After the patent expired in late 2017 and competitors created cheaper alternatives and generics, Viagra sales plummeted with 73% year-over-year for 2018.
Pfizer still holds the lead in the erectile dysfunction market with 65% even as Viagra sales falter. It’s been able to maintain that significant share thanks in part to launching Sildenafil, its own generic version of the blue, diamond-shaped pill. Cialis and its generic, Tadalafil, and Levitra and its generic, Vardenafil, are close behind with 30% and 5% of market share, respectively.
» Subscribe to CNBC
» Subscribe to CNBC TV
» Subscribe to CNBC Classic
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news
Follow CNBC on LinkedIn
Follow CNBC News on Facebook
Follow CNBC News on Twitter
Follow CNBC News on Instagram
#CNBC
#Viagra
How Viagra Made Pfizer Billions Before Generics
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.